Jump to start of content

Complete requirements by 12/31/19 to avoid a change in certification status Expand/Collapse the ABIM alert.

Sign in to your Physician Portal to view any remaining requirements for the year. Not completing these requirements by 12/31/19 could result in a change to your certification status.

Breadcrumb trail:

Pulmonary Disease Board Exam Committee

Expand All | Collapse All

Peter H. S. Sporn, MD, Chair

Peter H. S. Sporn, MD, ChairDr. Sporn, a board certified internist, pulmonologist and critical care specialist, is Professor of Medicine and Cell and Molecular Biology at the Feinberg School of Medicine of Northwestern University. He is Program Director of the Northwestern University Pulmonary and Critical Care Fellowship Program, a position he has held since 1996, and since which time he has directed the training of 75 pulmonary and critical fellows.

Since 2010, Dr. Sporn has been a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. His clinical interests include asthma, chronic obstructive pulmonary disease, eosinophilic respiratory diseases, interstitial lung diseases and sarcoidosis. His research interests include the role of eicosanoids in lung inflammation, eosinophil biology, mechanosignaling in lung injury and repair, innate immunity and lung host defense. He has been supported by the National Institutes of Health and the Department of Veterans Affairs throughout his research career.

Dr. Sporn received his undergraduate degree from the University of Chicago and his medical degree from Wayne State University School of Medicine. He trained in internal medicine at Bronx Municipal Hospital Center (now Jacobi Medical Center)/Albert Einstein College of Medicine and in pulmonary and critical medicine at the University of Michigan.

As of January 2017, Dr. Sporn reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • McGraw-Hill, receiving compensation for authorship of a chapter in Fishman's Pulmonary Diseases and Disorders, Fifth Edition.

Ellen L. Burnham, MD

Ellen L. Burnham, MDDr. Burnham is an Associate Professor of Medicine in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado. She is board certified in Pulmonary Disease and Critical Care Medicine. She is currently Medical Director for the University of Colorado Hospital Medical Intensive Care Unit and Associate Program Director for the Colorado Clinical and Translational Science Institute’s KL2 Program.

Previously, Dr. Burnham conducted National Institute of Health-sponsored research to understand the relationship between alcohol abuse and the development of pulmonary diseases that include pneumonia and the acute respiratory distress syndrome (ARDS). In this capacity, she has been the Principal Investigator for a clinically oriented research resource, known as the Colorado Pulmonary Alcohol Research Collaborative (CoPARC) to support translational research in the field. Additionally, she has served as a co-investigator in multi-center clinical trials testing new therapies for ARDS and sepsis. Dr. Burnham has also been a co-investigator for an NIH-supported mentoring training trial with other Clinical and Translational Science Institutes, and has co-authored a number of papers related to the importance of mentor support for clinical and translational research.

Dr. Burnham is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She is also an active member of the American Thoracic Society’s (ATS) Assembly on Critical Care, where she has previously served on the Planning Committee and is currently a member of the Programming Committee. She was Chair of the Women in Critical Care working group whose mission has been to improve women’s representation and diversity in the activities of ATS, and in critical care more generally. She is a member of ATS’s Tobacco Action Committee, where her focus is to address the emerging effects of cannabis use on lung health.

Dr. Burnham received biology and chemistry degrees from Texas Christian University, and her medical degree from the University of Texas-Southwestern Medical School. She completed house staff training at the University of Texas-Southwestern Medical School, and her pulmonary/critical care fellowship training at Emory University.

As of April 2019, Dr. Burnham reported the following external relationship:

Dr. Burnham serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Chair of Women in Critical Care, Tobacco Action Committee Member, without compensation.
  • Dr. Burnham also reported receiving University of California tobacco-related research grant funding.

Anne E. Dixon, MA, BM BCh

Dr. Dixon is Director of Pulmonary and Critical Care Medicine at the University of Vermont Larner College of Medicine. She is board certified in Pulmonary Disease and Critical Care Medicine.

Dr. Dixon has been an attending physician in the pulmonary and critical care division at the University of Vermont Medical Center since 2001. She has served on numerous committees for this organization, including serving as a member of the Board of Trustees of the University of Vermont Medical Group. She also leads an active research program in obesity and lung disease at the University of Vermont.

Dr. Dixon is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She has served on numerous national committees and review boards for the American Thoracic Society, the American Lung Association-Airways Clinical Research Centers, the National Institutes of Health and the Veteran’s Administration.

Dr. Dixon received a degree in natural sciences from the University of Cambridge and her medical degree from Oxford University. She completed residency training at the Johns Hopkins Hospital and fellowship training at the University of Washington.

As of October 2017, Dr. Dixon reported the following external relationship:

Work as an author or editor for following companies, with compensation as listed

  • Humana Press, receiving compensation for authorship on book on obesity and lung disease.

Dr. Dixon serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Association of Pulmonary, Critical Care and Sleep Division Directors, serving as President, without compensation.

Karen A. Fagan, MD

Karen A. Fagan, MDDr. Fagan graduated with BA and MD degrees from the University of California San Diego and completed internship and residency in Internal Medicine at the University of Texas Southwestern Medical School in Dallas, TX. After residency, she completed fellowship training in Pulmonary and Critical Care Medicine at the University of Colorado in Denver, CO. After fellowship, she joined the faculty in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado eventually rising to Associate Professor. At Colorado, she developed a clinical and scientific interest in pulmonary hypertension and received a NIH K08 award followed by R01s and other extramural and intramural funding.

She was recruited to the University of South Alabama (USA) in Mobile, AL as the Chief, Division of Pulmonary and Critical Care Medicine where she is now a Professor of Medicine and Pharmacology, member of the Center for Lung Biology and Director of the USA Pulmonary Hypertension Center. In addition, she has served on numerous committees and leadership positions in the Pulmonary Hypertension Association and the American Thoracic Society.

Dr. Fagan has maintained certification in Internal Medicine, Pulmonary Medicine and Critical Care Medicine continuously since 1995 and strongly supports the Mission of the ABIM to improve healthcare by certifying providers with the necessary knowledge to provide excellent care to their patients and the community. She lives in Spanish Fort, AL with her teenage twin daughters.

As of August 2018, Dr. Fagan reported the following external relationship:

Funding for clinical trial expenses, paid to the University of South Alabama, from the following companies:

  • United Therapeutics, for a trial of inhaled treprostinil in patients with interstitial lung disease and pulmonary arterial hypertension.

Post-marketing clinical research, with funding for expenses provided to the University of South Alabama, from the following companies:

  • Actelion, for a registry of patients with pulmonary arterial hypertension treated with selexipag.

Work as an author or editor for following companies, with compensation as listed:

  • UpToDate®, receiving annual royalties for online educational resource for lymphocytic interstitial pneumonia.

Dr. Fagan serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Member, Board of Directors; Chair, Pulmonary Circulation Assembly, receiving reimbursement for travel expenses.
  • Pulmonary Hypertension Association, Chair, Board of Trustees; Immediate Past-Chair of Scientific Leadership Council, receiving reimbursement for travel expenses.

Dr. Fagan also reported that she receives honoraria for serving on two data and safety monitoring boards for the National Institutes of Health for clinical trials on pulmonary arterial hypertension.

Joseph M. Forrester, MD

Joseph M. Forrester, MDDr. Forrester is President of Critical Care and Pulmonary Consultants, P.C. He has held this position, overseeing the pulmonary, critical care and internal medicine hospital care provided at the hospitals serviced by Critical Care and Pulmonary Consultants since 1995. The 85-physician practice provides outpatient and inpatient pulmonary and sleep services, inpatient critical care services, and hospitalist services to five hospitals in the Denver, Colorado metropolitan area. Dr. Forrester is also Director and Director of Hospitalist Services of the Intensive Care Unit at The Medical Center of Aurora.

Dr. Forrester served four years as a physician in the United States Navy, with two years at Bethesda Naval Hospital and the Uniformed Services Medical School. He is a Fellow of the American College of Physicians and the American College of Chest Physicians.

Dr. Forrester is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He is board certified in Internal Medicine, Pulmonary Disease, Critical Care Medicine and Sleep Medicine.

He earned a degree in chemistry from Kalamazoo College and a medical degree with high distinction from Wayne State University. Dr. Forrester completed his internal medicine house staff training and chief residency at The University of Michigan Hospitals and his pulmonary and critical care training at the University of Colorado Health Science Center.

As of January 2017, Dr. Forrester reported no external relationships.

Neil S. Freedman, MD

Neil S. Freedman, MDDr. Freedman is the Division Head of Pulmonary, Critical Care, Allergy and Immunology at the Northshore University Health System in Evanston, Illinois. He holds the academic rank of Clinical Associate Professor of Medicine at the University of Chicago Pritzker School of Medicine and he is board certified in Pulmonary Disease, Critical Care Medicine and Sleep Medicine. At Northshore, he spends approximately 80% of his time in direct patient care activities with the remainder of his time dedicated to administrative responsibilities. In addition to his clinical and administrative roles, he serves on the Board of Trustees of The Northshore Medical Group Faculty Practice Associates and is Vice President of the Professional Staff.

Previously, Dr. Freedman was in private practice for 12 years as a partner in Pulmonary Physicians of the Northshore in Bannockburn, Illinois.

Dr. Freedman is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has volunteered for several professional societies in leadership and educational roles. He currently serves as a member American College of Chest Physicians (ACCP) Chest Foundation Board of Trustees, has recently chaired the ACCP sleep network and previously served on the ACCP joint finance oversight and education committees. He has been a member of the ACCP and Associated Professional Sleep Societies scientific program committees and was the chair of the scientific program committee for CHEST Annual meeting in 2016.

Dr. Freedman has delivered more than 250 presentations at national and international meetings on the topics of sleep, pulmonary and critical care medicine. He has chaired post-graduate courses and general sessions at national meetings for several professional societies and recently was the chair of the ACCP Sleep Medicine Board Review Course from 2013 to 2016. He has been recognized for his educational efforts with the Excellence in Education Award from the American Academy of Sleep Medicine in 2016 and the ACCP Distinguished Chest Educator in 2017.

Dr. Freedman received a biology degree from Washington and Jefferson College in Washington, Pennsylvania, and his medical degree at the Mount Sinai School of Medicine in New York. He completed his internship and residency in internal medicine and fellowships in pulmonary, critical care and sleep medicine at the Hospital of the University of Pennsylvania.

As of October 2017, Dr. Freedman reported the following external relationship:

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Dr. Freedman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Chest Physicians, Member of Board of Trustees, Faculty Member travel/honoraria, receiving reimbursement for travel expenses and honoraria.
  • American Academy of Sleep Medicine, Faculty Member, receiving reimbursement for travel expenses and honoraria.

Nishant Gupta, MD, MS

Nishant Gupta MD, MS Dr. Gupta completed his medical training at the University of Delhi, India, followed by internal medicine residency at the University of Tennessee and fellowships in pulmonary and critical care medicine at the University of Cincinnati. In addition, he has completed fellowship training in the field of rare lung diseases, as well as a master’s degree in Clinical and Translational Research at the University of Cincinnati. Dr. Gupta is ABIM Board Certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine, and is participating in Maintenance of Certification. Dr. Gupta is currently an Associate Professor in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Cincinnati, where he serves as the director of the interstitial and rare lung diseases program. Dr. Gupta is also the medical director of the international lymphangioleiomyomatosis (LAM)/rare lung disease clinic network. Dr. Gupta's clinical and research focus is rare lung diseases such as LAM, and his work is aimed at better defining the natural history, improving detection, and developing novel treatment modalities and monitoring strategies for patients with rare lung diseases.

As of August 2019, Dr. Gupta reported the following external relationships:

Funding for clinical trial expenses, salary support and staff, paid to University of Cincinnati from the following companies:

  • Bellerophon Therapeutics, Site Principal Investigator, receiving funding for salary support and project expenses.
  • Boehringer Ingelheim, Site Principal Investigator, receiving funding for salary support and project expenses.

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Dr. Gupta serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The LAM Foundation, Member, Scientific Advisory Board, without compensation.
  • TSC Bio-Sample Repository and Natural History Database Project, Steering Committee Member, without compensation.

Nadia N. Hansel, MD

Nadia N. Hansel, MDDr. Nadia Hansel is a Professor of Medicine and Interim Director of the Division of Pulmonary and Critical Care Medicine at Johns Hopkins with joint appointments in the Division of Allergy and Clinical Immunology at the Johns Hopkins School of Medicine and the Department of Environmental Health Sciences at the Johns Hopkins Bloomberg School of Public Health. She assumed the position of the Associate Dean of Research for the Bayview Campus, Johns Hopkins University School of Medicine in July 2014. Dr. Hansel serves on the Anmerican Board of Internal Medicine Pulmonary Disease Exam Board.

Dr. Hansel received her undergraduate degree magna cum laude in biology from Harvard College and her medical degree from Harvard Medical School. She completed her internal medicine residency at the University of Pennsylvania and came to Johns Hopkins University to complete her Pulmonary and Critical Care fellowship. She subsequently completed her Masters of Public Health Degree from the Johns Hopkins Bloomberg School of Public Health. Dr. Hansel's research is focused on environmental determinants of obstructive lung diseases. She is widely recognized as an international expert in defining the indoor air quality on asthma and chronic obstructive pulmonary disease (COPD) health.

Her work is funded by the National Institutes of Health, Housing of Urban Development and the Environmental Protection Agency. Dr. Hansel is the Director of the Johns Hopkins Center for the Study of the Childhood Asthma in the Urban Environment (CCAUE) and the Director of the Johns Hopkins Center of Excellence on Environmental Health Disparities Research. Dr. Hansel serves on numerous editorial boards and professional organizations, is frequently an invited speaker nationally and internationally to present her research and has published over 150 peer reviewed publications. She received the David M. Levine Excellence in Mentoring Award in recognition of her dedication to training future physician scientists.

As of September 2018, Dr. Hansel reported the following external relationships:

Funding for clinical trial expenses, salary support and staff, paid to Johns Hopkins University from the following companies:

  • Boehringer Ingelheim, for an observational study in healthy subjects and patients with chronic obstructive pulmonary disease to assess the relationship between clinical, imaging and biomarker measurements, and progression of emphysema over two years.

David E. Ost, MD

David E. Ost, MDDr. Ost is Professor of Medicine at The University of Texas MD Anderson Cancer Center. He is board certified in Pulmonary Disease and Critical Care Medicine. He is Director of Clinical Research in the Department of Pulmonary Medicine.

Dr. Ost joined the Department of Pulmonary Medicine at MD Anderson Cancer Center in 2008. Prior to this he was an Associate Professor at New York University School of Medicine in the Division of Pulmonary and Critical Care Medicine and Director of Interventional Pulmonology from 2005 to 2008. From 1996 to 2005, he was Director of Interventional Pulmonology at North Shore-Long Island Jewish Medical Center.

Dr. Ost is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has served on the Board of Directors of the American Association for Bronchology and Interventional Pulmonology. He was awarded the Pasquale Ciaglia Memorial Award in Interventional Pulmonology in 2013. He is an associate editor for the Journal of Bronchology and Interventional Pulmonology and the Annals of the American Thoracic Society. He was winner of the Alfred Soffer Research Award in 2006.

Dr. Ost graduated from the Pennsylvania State University with a bachelor's degree in science in 1986. He graduated from Jefferson Medical College in 1990. He completed an internship and residency in Internal medicine at Northwestern University in 1993. He completed a fellowship in pulmonary and critical care medicine at Northwestern University in 1996. He also has a master's degree in public health from the Harvard School of Public Health.

As of January 2017, Dr. Ost reported the following external relationships:

Funding for clinical trial expenses from the following company:

  • Fresh Medical Laboratories, serving as the site principal investigator for a clinical trial of a tool for early detection of lung cancer as an adjunct to lung CT in the evaluation of patients with pulmonary lesions suspicious for lung cancer.

Service on a research-related expert panel or advisory board for the following company, with compensation for honoraria:

  • Vida, for looking at CT imaging data sets to do volumetric measurement of lung nodules and precision imaging for lung cancer surgery.

Work funded by educational grants from industry for staff, paid to MD Anderson Cancer Center, from the following company:

  • Pulmotect, for research on pneumonia in parainfluenza virus.

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for authorship.

Mindy S. Shapiro, MD

Mindy S. Shapiro, MDDr. Shapiro is the Medical Director of the Intensive Care Unit of Kaiser Permanente Santa Rosa Medical Center, Santa Rosa, California, and a practicing pulmonologist in The Physicians Medical Group of Northern California. She is board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine.

Dr. Shapiro is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She has served on the Medical Executive Committees of Sunrise Hospital and Desert Springs Hospital Medical Center in Las Vegas, Nevada. She was the founding Medical Director of IntensiCare Corporation, a hospitalist company based in San Diego, California.

Dr. Shapiro received a bachelor's degree in biology from Radcliffe College, Harvard University. She received her medical degree from Johns Hopkins University School of Medicine. She was a member of the Osler Medical Housestaff Program of the Johns Hopkins Hospital, and she completed her pulmonary and critical care fellowship at Yale University Hospitals.

As of January 2017, Dr. Shapiro reported no external relationships.